Effect of intensive insulin therapy on β-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial
- 1 May 2008
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 371 (9626), 1753-1760
- https://doi.org/10.1016/s0140-6736(08)60762-x
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Islet cell failure in type 2 diabetesJCI Insight, 2006
- Metabolic memory in diabetes-focus on insulinDiabetes/Metabolism Research and Reviews, 2004
- Induction of Long-term Glycemic Control in Newly Diagnosed Type 2 Diabetic Patients Is Associated With Improvement of β-Cell FunctionDiabetes Care, 2004
- The pathophysiological basis for intensive insulin replacementInternational Journal of Obesity, 2004
- Insulin‐like growth factors and pancreas beta cellsEuropean Journal of Clinical Investigation, 2004
- [LysB3, GluB29] insulin: a novel insulin analog with enhanced β-cell protective actionBiochemical and Biophysical Research Communications, 2003
- Methods for clinical assessment of insulin sensitivity and β-cell functionBest Practice & Research Clinical Endocrinology & Metabolism, 2003
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)The Lancet, 1998
- Induction of Long-Term Glycemic Control in Newly Diagnosed Type 2 Diabetic Patients by Transient Intensive Insulin TreatmentDiabetes Care, 1997